Jump to:

Disease/ Disorder


True visceral pain is a physiologically and clinically separate entity from somatic pain.  Visceral pain responses are provoked by ischemia, inflammation, and distention. Visceral pain is poorly defined and diffuse and commonly described as deep, gnawing, twisting, aching, colicky, or dull.1 It is usually associated with autonomic features (e.g., sweating, nausea and vomiting) and highly emotional (e.g., anxious, feeling of impending doom).


The cell bodies for the sympathetic nervous system originate from the intermediolateral column of the spinal cord between T1 and L2/3.  The paravertebral sympathetic ganglia are arranged in two chains spanning from the skull to the coccyx along the anterior aspect of the vertebral column and terminate in the only unpaired ganglion of the sympathetic chain, the ganglion impar (ganglion of Walther) on the ventral surface of the coccyx.  After synapsing in the sympathetic ganglia, post ganglionic C fibers can rejoin the spinal nerve via the gray rami communicates at any spinal level and continue onward as postganglionic fibers to exert their end effect.2

Visceral pain fibers, which are Aδ or C fibers, follow a similar path as described above with the sympathetics, but in an afferent manner.  It is this overlapping pathway that generates the non-discrete pain from abdominal or pelvic viscera.




  • Stomach
  • Duodenum
  • Liver
  • Gallbladder
  • Bile ducts
  • Pancreas


  • Small bowel
  • Proximal colon
  • Appendix


  • Distal colon
  • Genitourinary tract


  • Aorta
  • Kidneys
  • Ureters


  • Muscular endopelvic fascial lining
    • Levator ani
    • Coccygeus
  • Organs
    • Rectum
    • Bladder
    • Uterus
    • Ovaries
    • Prostate
    • Vulva/Scrotum
    • Urethra
    • Perianal region


Organ Inflammation

  • Chemical irritation
    • Enzymatic
      • Gastric
      • Biliary
      • Pancreatic
      • Duodenal
    • Infection
      • Parenchymal
      • Organ capsule
      • Interstitium
    • Mechanical irritation
      • Nephrolithiasis, cholelithiasis
      • Neoplasm
      • Fibroids

Disruption of normal mechanical processes

  • Organ obstruction and distention
    • Neoplasm
      • Benign
      • Malignant
    • Calculi
    • Stenotic ducts
    • Increased peristalsis
    • Decreased peristalsis
    • Muscle spasm


  • Impaired circulation:
    • Thrombus
    • Embolism
    • Hypotension

Clinical Variants of Abdominal and Pelvic Visceral Pain

  • True Visceral Pain
    • Nociception arises from pain fibers in deep lying abdominal or pelvic organs
    • (+) tissue injury
  • Visceral Hyperalgesia
    • Slow, poorly localized i.e., colic
    • Proposed Mechanisms:
      • Sensitization of primary sensory afferents innervating the viscera (e.g., direct tissue injury via PEG tube placement)
      • Hyperexcitability of spinal ascending neurons (central sensitization) receiving synaptic input from the viscera (e.g., irritable bowel syndrome)
      • Dysregulation of descending pathways that modulate spinal nociceptive transmission (e.g., SCI, TBI, CVA)
      • Alternation in sensory neurons so that they are more responsive to naturally occurring stimuli. (peripheral) An enhanced sensitivity of the sensory pathways in the brain (central). (e.g., TBI, CVA)
  • Viscero-Viscero Hyperalgesia
    • Sensory interaction between two different organs that share the same sensory pathway
  • Viscero-Somatic Pain
    • Pain experienced in a somatic portion of the body secondary to organ irritation due to shared somatic and visceral innervation (e.g., Left shoulder pain secondary to a ruptured spleen)
  • Somato-Visceral
    • Pain experienced in a visceral portion of the body secondary to somatic irritation due to shared visceral and somatic innervation based on viscerosomatic convergence (e.g., abdominal visceral pain secondary to injured paraspinal muscles)3

Epidemiology including risk factors and primary prevention

Chronic pelvic pain (CPP) prevalence is estimated between 4 and 15%. 21% of healthy individuals and 24% in people of age 65 and older have a minimum of six episodes of abdominal pain and discomfort per year.4

Risk factors


  • Distorted/altered anatomy
  • Increased risk of visceral hyperalgesia
  • Adhesions
    • Surgical approach
      • Use of peritoneal mesh
    • Age
    • Type of procedure


  • Malignancy
  • Organ ischemia


  • Malignancy
  • Pancreatitis
  • Cholelithiasis
  • Cirrhosis


  • Periabdominal fat
  • Gastritis
  • Low fiber diet (i.e., constipation)


  • Hypomotility
  • Diabetic neuropathy (i.e., gastroparesis)


  • Childbirth (i.e., organ prolapse)


Psychosocial factors

  • History of sexual abuse
  • Somatoform disorder

Disease progression including natural history, disease phases or stages, disease trajectory (clinical features and presentation over time)

Clinical features have a temporal evolution and vary in different phases of pathology. Clinical courses vary with etiology. Infectious sources may present rapidly and improve rapidly as the source is treated. Postsurgical pain has a sudden onset but may worsen following surgery due to mechanical or neural disrepair of peri-surgical tissue. Treatment is usually conservative and involves multiple treatment modalities. Tumor invasion commonly presents insidiously and gradually worsens with tumor growth. Resection, radiation/chemotherapy treatment, and interventional pain procedures may improve symptoms.3

Specific secondary or associated conditions and complications

Can be associated with autonomic phenomena such as:

  • Pallor
  • Profuse sweating
  • Nausea
  • Gastrointestinal disturbances
  • Changes in body temperature
  • Hypotension
  • Tachycardia

Essentials of Assessment


  • The onset is often insidious
  • Pain is poorly localized. Exceptions include biliary, pancreatic, renal, appendix
  • True visceral pain is dull/colicky pain, but depending on the etiology the pain can transform to sharp
  • Exacerbating factors
    • Abdomen
      • Commonly worse with eating
    • Pelvis
      • Worse with urination, sexual intercourse, or defecation
  • Dysautonomia
    • Nausea
    • Vomiting
    • Pallor
    • Diaphoresis
    • Restlessness
  • Medical history
    • Diabetes
    • Anxiety/depression
    • Post-traumatic stress disorder
    • Cancer
    • Female patients: menstrual cycle, pregnancy
  • Surgical history
    • Abdominal/pelvic surgeries
  • Social history
    • Tobacco, alcohol, illicit substance use
    • Sexual trauma
    • Living situation

Physical examination

  • Review the vital signs prior to seeing the patient: looking for tachycardia, tachypnea, fever
  • Assessment of patient’s appearance, position on the exam table, and degree of discomfort
  • Perform and cardiac and pulmonary exam
  • Inspect for surgical scars and skin discoloration
  • Auscultate the abdomen listening for increase/decreased activity and pitch of bowel sounds and bruits
  • Percuss the abdomen for detection of hepatomegaly, tympany, shifting dullness
  • Palpation of the abdomen/pelvis for areas of tenderness, signs of peritoneal inflammation (pain out of proportion to exam), masses, pulsations, hernias, ascites
  • Abdominal special tests
    • Abdominal wall pain: Carnett’s sign (sensitivity 78% specificity 88%)- with the patient supine, palpate the tender area, then ask them to tense their abdomen by either raising their head/shoulder off the table or lifting both straightened legs off the table5. The test is positive if the pain worsens.
    • Renal pathology: Flank percussion (Murphy’s punch)
    • Biliary pathology: Murphy’s sign
    • Appendicitis: psoas, obturator, Rovsing’s signs
    • Ascites: shifting dullness, fluid wave
  • Rectal examination if complaining of peri-anal pain
    • Manual prostate examination
      • Pain
      • Bogginess
      • Mass
  • Pelvic examination if complaining of dyspareunia or vulvodynia
    • External examination
      • Inspection of external genitals for scars, uterine/rectal prolapse, sexual transmitted diseases
      • Palpation of pelvic floor assessing for trigger points in the ischiocavernosus, bulbocavernosus, superficial transverse perineal, external anal sphincter, and the anterior/posterior levator ani muscles
    • Internal Examination
      • The cervix is inspected for discharge, uterine prolapse, and cervical stenosis or lesions. Bimanual examination should assess cervical motion tenderness, adnexal masses or tenderness, and uterine enlargement or tenderness.
        • Trigger points can be assessed during the bimanual exam. Specific muscles include ischiocavernosus, bulbocavernosus, superficial/deep transverse perineal, coccygeous, piriformis, obturator internus, and the anterior/posterior levator ani muscles

Clinical functional assessment: mobility, self-care and cognition/behavior/affective state

  • Chronic abdominal/pelvic pain has strong association with psychological comorbidities
    • Depressed mood
    • Anxiety
    • Anorexia
    • Poor Focus
    • History of sexual abuse
    • Postprandial pain, pain with defecation, dyspareunia
    • Validated Measures
      • Functional Bowel Disease Severity Index
      • Inflammatory Bowel Severity Scale
      • Pelvic Girdle Questionnaire
      • Chronic Prostatitis Symptom Index

Laboratory studies

  • Blood
    • Lactate
    • ESR/CRP
    • Amylase/lipase/calcium
    • Bilirubin
    • Beta hCG
    • Auto-immune labs if there is clinical suspicion as many conditions can present with visceral pain6
  •  Urine
    • Infectious
      • Bacteria/WBC/Leukocyte esterase/Nitrite/Culture
    • Vasculitis
      • RBC/WBC/Casts
  • Stool
    • Blood
    • Leukocytes
    • Lipids
    • Parasites
    • Bacteria
  •  Semen/Vaginal
    • Infectious
      • Chlamydia/Gonorrhea
  • Malignancy
    • CEA (Gut)
    • CA 195 (Gut)
    • Gastrin (Gastrinoma)
    • CA19-9 (Ovarian/Pancreatic)
    • CA 125 (Ovarian)
    • TPA (Non-specific for gynecologic, bladder, lung)
    • PSA (Prostate)
    • AFP (Liver/Reproductive)


A wide range of imaging are utilized based of the physician’s clinical suspicion. For example, a patient in an emergency setting presenting with acute severe visceral pain might be screened with an ultrasound then have CT if the ultrasound findings are inconclusive.

  • Ultrasound
    • Neoplasm
    • Cholecystitis
    • Cholelithiasis
    • Calculi
    • Cysts
    • Free fluid/air
    • Varicosities
  • Radiograph
    • Gastric/Colon Paresis
    • Calculi
    • Masses
  • Barium GI Series
    • Obstruction
      • Mechanical
      • Metabolic
        • Decreased peristalsis
  • CT
    • Inclusive of US findings and:
    • Appendicitis
    • Organ distension
    • Aortic aneurysm
    • Organ wall thickening
    • Diverticulitis
    • Nephrolithiasis
    • Cystitis
    • Prostatitis
    • Proctitis
    • Fistula
    • Adhesions
  • MRI
    • Inclusive of CT findings and:
      • Active inflammation
      • Organ blood flow analysis
    • Magnetic Resonance Cholangiopancreatography (MRCP)
  • Invasive
    • Endoscopy/Colonoscopy
      • Lumen analysis
        • Mass
        • Ulceration
        • Polyps
        • Biopsy
    • ERCP
      • Foregut duct obstructions
    • Cystoscopy
      • Ulcer
      • Glomerulations
      • Cancer

Supplemental assessment tools

  • Pelvic EMG- evaluate for pelvic floor dysfunction
  • Vaginal manometry
  • Pap smear – to evaluate for possible malignancy
  • Rectal manometry
  • Diagnostic celiac plexus block for evaluation of foregut dysautonomia
  • Barium contrast studies
  • Diagnostic superior hypogastric plexus block for evaluation of pelvic visceral etiology
  • Behavioral evaluation
  • Psychologic evaluation
    • Depression Questionnaire (i.e. PHQ-2, PHQ-9, Geriatric Depression Scale)

Early prediction of outcomes

Early outcome predictors may include vocational status, psychologic status, motivation, medication consumption, family relationships, emotional distress, pain intensity, and objective initial physiotherapeutic response measures. Pain assessment scales such as the McGill Pain questionnaire can also be utilized7.


Chronic visceral pain can lead to psychologic disability and may require a social worker to assist with frequent home assessments. It is important to evaluate home social dynamics as there is an association between chronic abdominal and pelvic pain in patients who suffer from physical and sexual abuse.

Social role and support system

Many diagnoses can cause visceral pain that have their own support groups. On-line support groups exist for each condition. In addition, some hospitals have behavioral therapy groups that patients may enter for more intimate discussions.

Professional issues

Many patients with chronic abdominal/pelvic pain are treated with opiate medications. Treatment of chronic visceral pain refractory to various interventions may lead to the misuse and abuse of these which can present as an ethical dilemma. Patient safety must also be considered when prescribing opioids. According to the Center for Disease Control & Prevention, opioids (both prescribed and illicit) were involved in 67.8% of deaths by drug overdose.8

Rehabilitation Management and Techniques

Available or current treatment guidelines

Generally accepted treatment for visceral pain includes treating the underlying pathology. This pathology, in many cases of visceral pain, is either caused by infection, ischemia, inflammation or malignancy of the involved organ system. Treatment is directed at the pathology. In the cases of ischemia and inflammation and ischemia, surgical intervention is often times required. In cases where an organic pathology is not clear, diagnostic percutaneous sympathetic blocks can be performed. In malignant cases refractory to surgical or chemotherapeutic treatment, repeat therapeutic percutaneous sympathetic blocks or ablative procedures may be performed.

At different disease stages

New onset/acute: It is essential to confirm accurate diagnosis, as visceral pain is generally poorly localized and can mimic other pathologies within the abdomen and pelvis. Once confirmed, visceral and pelvic pain may improve or resolve with appropriate treatment. A surgical evaluation may be necessary for certain diagnoses [e.g., bowel obstruction, cholecystitis, appendicitis (both visceral and somatic), etc.].

  • Intravenous analgesia (inpatient only, typically post-operatively):
    • Ibuprofen
    • Acetaminophen
    • Opiates
    • Ketamine
  • Oral analgesia:
    • Nonsteroidal anti-inflammatories
    • Acetaminophen
    • Antiseizure medications
    • Nonselective serotonin reuptake inhibitors
    • Antispasmodics
    • Opioids as a last line therapy
  • Topical:
    • Lidocaine
    • Prilocaine/lidocaine
    • Capsaicin
      • not to be used on mucosal surfaces
    • Rehabilitation- involves early mobilization, transfers, bed mobility, wound care. May require stay in acute rehabilitation setting depending on diagnosis and surgical intervention performed.
  • Percutaneous Sympathetic Blocks:
    • Few reports have evaluated optimal timing for celiac plexus neurolysis, some suggest for those with malignant disease, neurolysis may be more effective when performed early before development of a substantial viscero-somatic component, leading some authors to advocate for its use as a first-line treatment modality.9
    • Idiopathic coccydynia, though not a true visceral etiology, is another indication as the coccygeal plexus or its branches can be involved.2

Subacute and Chronic Phase: Involves transition to home setting as well returning to work and normal daily activities. Patients may need ongoing outpatient rehabilitation focusing on mobility, scar management, desensitization techniques, TENS. Includes all of the above as well as use of percutaneous sympathetic blocks.

  • Chronic abdominal pain associated with malignancy secondary to direct invasion or mass effect on viscera and surrounding structures by pancreatic, biliary, and gastric cancers, or metastases from hematogenous or lymphatic spread is a common indication for sympathetic blocks. It is estimated that around 10% of cancer patients with visceral pain fail pharmacological treatments and require interventional management10.
  • Nonmalignant sources of chronic abdominal pain include chronic pancreatitis from inflammatory processes or from biliary pathology like common bile duct stenosis11 and is composed of pre- and postganglionic sympathetic, parasympathetic and visceral sensory afferents fibers.
    • For pelvic viscera-associated pain, possible interventions include superior hypogastric plexus (SHP) blocks, inferior hypogastric plexus (IHP) blocks, and the ganglion impar block.12
      • In cancer patients, it was shown that opioid consumption is significantly decreased up to six months following a SHP block due to significantly better pain control.13
    • For patients with successful sympathetic blocks, neurolytic blocks are a mainstay in the management of cancer pain and may be performed with either phenol or alcohol for longer lasting relief2.
      • The complication rate from celiac plexus neurolysis (CPN) or splanchnic nerve neurolysis (SNN) with either treatment is low, estimated to be 1 – 2%.14
    • Radiofrequency ablation of the splanchnic nerves is an option, though infrequently performed for cancer pain.

Coordination of care

  • Development of acute pain service for management of postoperative pain.
  • Providing multimodal analgesia to improve postoperative pain treatment.
  • Patients should be managed by an extended multidisciplinary team (pain, GI/Ob/gyn, surgery, rehabilitation, psychiatry) and enrolled in psychologist-administered support groups specific to the etiology of pain.

Patient & family education

Visceral pain can be ambiguous and difficult to understand. Therefore, it is very important for the patient to be educated on the disease process, treatments, and possible complications. It is especially important for the patient’s family to be well-versed on the patient’s disease to help foster a supportive environment for the patient.

Measurement of Treatment Outcomes including those that are impairment based, activity participation-based and environmentally based

The Pain Disability Questionnaire, 12-Item Short-Form Health Survey or Medical Outcomes Study 36-Item Short-Form Health Survey, and the Oswestry and McGill Pain Questionnaire can be used to monitor overall efficacy of treatments, functional improvement, and quality of life.

The Functional Bowel Disease Severity Index, Inflammatory Bowel Severity Scale, Pelvic Girdle Questionnaire, Chronic Prostatitis Symptom Index are outcome measures specifically designed to measure pain and quality of life in patients with abdominal and pelvic pain.

The Visual Analog Scale (VAS) can be used to rate an individual’s intensity of pain helping measure the effectiveness of treatments by comparing pre- and post-treatment VAS scores.

Translation into practice: practice “pearls”/performance improvement in practice (PIPs)/changes in clinical practice behaviors and skills

  • Spectrum of care includes education, activity modification, medication management, and surgery if the inciting agent is operable. The WHO stepladder for analgesia may be a useful tool to aid with medication management. Once conservative treatment is fully utilized, interventional procedures should be considered to help reduce intractable pain. However, in patients with terminal diagnoses with significant pain, these procedures should be considered as early as possible.
  • Physical therapy offers multiple non to minimally invasive modalities for treatment which are generally well-tolerated. More research is needed to prove the efficacy of the listed modalities in a multitude of pain etiologies.
    • Myofascial induction/manual manipulation/ therapy: has been shown to decrease pain related to scar formation.15,16
    • Auricular acupuncture: possible therapy for acute abdominal pain.4
    • Yoga: proposed to improve pain associated with irritable bowel syndrome in children.17
    • Neuromuscular therapy: suggested as an alternate therapy for women with dysmenorrhea.18
    • Dry needling: has been shown to improve pain related to trigger points.19,20
    • Dry cupping: minimally invasive, however has not reliably demonstrated improvement of pain specifically related to trigger points.16,19
    • Transcutaneous electrical nerve stimulation: improvement in pain related to many abdominal/pathologies including chronic pelvic pain and constipation related abdominal pain.21,22

Cutting Edge/ Emerging and Unique Concepts and Practice

  • Ablation of abdominal and pelvic tumors.
    • Investigational procedures.
    • Demonstrated preliminary efficacy.
  • Spinal cord, vagus, and splanchic stimulation technology have produced variable successful reports for abdominal pain.
    • Conus medullaris and sacral stimulation products (dorsal root ganglion stimulation) are currently being improved for refractory sacral pain indication but have thus far produced marginal success in the literature.23
  • Radiofrequency ablation (RFA) techniques:
    • Conventional RFA carries a risk of inadvertent damage to motor nerves secondary to the thermocoagulation effect.
    • Pulsed radiofrequency (PRF) treatment is carried out in similar fashion as conventional RFA; however, the current is typically carried out in 20-ms pulses every 0.5 s at a temperature that does not exceed 42 °C.24,25 This lower temperature allows for a non-ablative, neuromodulatory treatment, thus sparing motor or sensory destruction.
      • Studies show a significant decrease in VAS scores when SHP is coupled with PRF vs SHP alone in the treatment of chronic pelvic and perineal pain related to pelvic cancer. This also results in significantly decreased opioid consumption through the first 6 months s/p procedure.26
  • Spinal Cord Stimulation
    • Traditional Frequency:
      • 50-100 Hz
      • Produces paresthesias in the abdomen and pelvis, altering pain transduction
      • Support for successful symptom control with lead placement at the conus medullaris or the mid‐thoracic region.23
      • Further studies are needed to explore this as a reliable and viable option in specific etiologies of visceral pain.
      • While dorsal column stimulation has shown great promise, alternative technology outside the dorsal column focused on concentrating current in the dorsal root ganglion or targeting individual nerves as demonstrated through peripheral nerve stimulation has demonstrated efficacy in case series.27
  • Intrathecal Therapy
    • May be used after failure of oral medical management
      • Opiates
        • Morphine
        • Fentanyl
        • Sufentanyl
        • Dilaudid
        • Methadone
      • Local Anesthetics
        • Bupivacaine
        • Lidocaine
      • Other
        • Clonidine
        • Ketamine
        • Baclofen
        • Ziconitide
  • Neuraxial Neurolysis
    • Alcohol neurolysis can be performed by laying patient on their side with painful side up due to the hypobaricity of alcohol in CSF. If phenol is used, patient would be laying with painful side down. Agent is injected to nerve roots and patient maintains position for 30 minutes.
      • Can provide profound pain relief but can cause irreversible motor paralysis and bowel/bladder incontinence. For these reasons this procedure is rarely used and reserved for cancer patients with refractory pain and short life expectancies.10
  • Tetrodotoxin
    • Some animal and clinical studies have shown some potentially promising analgesic effects, specifically with GI sourced visceral pain, with the use of Tetrodotoxin.
    • The toxin specifically works on Voltage-gated sodium channels by dampening the firing of Action Potentials, thus diminishing pain transduction.28

Gaps in the Evidence Based Knowledge

There are many gaps in the evidence-based knowledge in visceral pain originating from the abdomen and pelvis. Chronic pelvic and abdominal pain may or may not have a clear organic etiology. Visceral pain, by definition of its local ambiguity, clouds identification of pain and can be challenging to accurately diagnose these patients. For patients without evident organic findings behavioral and psychologic comorbidities diagnosis may be even more difficult. Often complicated by a behavioral or psychologic diagnosis one cannot rule out concomitant somatoform or neuropathy (dysautonomia). Therefore, epidemiology, medical, interventional, rehabilitation, and psychologic treatment are very challenging.


  1. Sykes N, Bennet M CY. Cancer pain management in the community setting. In: Gibbs M, Robinson V, Sykes, N MC, ed. Clinical Pain Management. CRC Press; 2008.
  2. Nagpal AS, Vydra D, Correa J, Zoch IA, Boies BT. Evidence Analysis of Sympathetic Blocks for Visceral Pain. Curr Phys Med Rehabil Reports. May 2019. doi:10.1007/s40141-019-00226-7
  3. Sikandar S, Dickenson AH. Visceral pain: The ins and outs, the ups and downs. Curr Opin Support Palliat Care. 2012. doi:10.1097/SPC.0b013e32834f6ec9
  4. Origoni M, Leone Roberti Maggiore U, Salvatore S, Candiani M. Neurobiological mechanisms of pelvic pain. Biomed Res Int. 2014. doi:10.1155/2014/903848
  5. Srinivasan R, Greenbaum DS. Chronic abdominal wall pain: A frequently overlooked problem. Practical approach to diagnosis and management. Am J Gastroenterol. 2002. doi:10.1016/S0002-9270(02)04018-2
  6. Merz EL, Malcarne VL, Roesch SC, et al. Longitudinal patterns of pain in patients with diffuse and limited systemic sclerosis: integrating medical, psychological, and social characteristics. Qual Life Res. 2017. doi:10.1007/s11136-016-1370-y
  7. Mystakidou K, Parpa E, Tsilika E, et al. Greek McGill pain questionnaire: Validation and utility in cancer patients. J Pain Symptom Manage. 2003. doi:10.1016/S0885-3924(02)00495-5
  8. Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 2018. doi:10.15585/mmwr.mm675152e1
  9. Cornman-Homonoff J, Holzwanger DJ, Lee KS, Madoff DC, Li D. Celiac Plexus Block and Neurolysis in the Management of Chronic Upper Abdominal Pain. Semin Intervent Radiol. 2017. doi:10.1055/s-0037-1608861
  10. Wie C, Ghanavatian S, Pew S, et al. Interventional Treatment Modalities for Chronic Abdominal and Pelvic Visceral Pain. Curr Pain Headache Rep. 2022;26(9):683-691. doi:10.1007/s11916-022-01072-4
  11. Vijungco JD, Prinz RA. Management of Biliary and Duodenal Complications of Chronic Pancreatitis. World J Surg. 2003. doi:10.1007/s00268-003-7246-7
  12. Nagpal AS, Moody EL. Interventional Management for Pelvic Pain. Phys Med Rehabil Clin N Am. 2017. doi:10.1016/j.pmr.2017.03.011
  13. Rocha A, Plancarte R, Nataren RGR, Carrera IHS, Pacheco VALR, Hernandez-Porras BC. Effectiveness of Superior Hypogastric Plexus Neurolysis for Pelvic Cancer Pain. Pain Physician. 2020;23(2):203-208.
  14. Koyyalagunta D, Engle MP, Yu J, Feng L, Novy DM. The Effectiveness of Alcohol Versus Phenol Based Splanchnic Nerve Neurolysis for the Treatment of Intra-Abdominal Cancer Pain. Pain Physician. 2016.
  15. Chamorro Comesaña A, Suárez Vicente M del P, Docampo Ferreira T, Pérez-La Fuente Varela M del M, Porto Quintáns MM, Pilat A. Effect of myofascial induction therapy on post-c-section scars, more than one and a half years old. Pilot study. J Bodyw Mov Ther. 2017. doi:10.1016/j.jbmt.2016.07.003
  16. Inanmdar W, Sultana A, Mubeen U, Rahman K. Clinical efficacy of Trigonella foenum graecum (Fenugreek) and dry cupping therapy on intensity of pain in patients with primary dysmenorrhea. Chin J Integr Med. 2016. doi:10.1007/s11655-016-2259-x
  17. Evans S, Seidman LC, Lung K, Sternlieb B, Zeltzer LK. Yoga for Teens with Irritable Bowel Syndrome: Results from a Mixed-Methods Pilot Study. Holist Nurs Pract. 2018. doi:10.1097/HNP.0000000000000288
  18. Barassi G, Bellomo RG, Porreca A, Di Felice PA, Prosperi L SR. Visceral Effects in the Treatment of Dysmenorrhea: Neuromuscular Manual Therapy and Standard Pharmacological Treatment. J Altern Complement Med. 2018;24(3):291-299. doi:doi: 10.1089/acm.2017.0182
  19. Rajkannan P, Vijayaraghavan R. Dry needling in chronic abdominal wall pain of uncertain origin. J Bodyw Mov Ther. 2019. doi:10.1016/j.jbmt.2018.01.004
  20. Charles D, Tan J, Newman E, Wigger M, Hudgins T, MacNaughton J. A Comparison of Dry Cupping and Dry Needling in Reducing Myofascial Trigger Point Associated Pain. Arch Phys Med Rehabil. 2017. doi:10.1016/j.apmr.2017.08.448
  21. Sharma N, Rekha K, Srinivasan J. Efficacy of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain. J Midlife Health. 2017. doi:10.4103/jmh.jmh_60_16
  22. Yik YI, Hutson J, Southwell B. Home-Based Transabdominal Interferential Electrical Stimulation for Six Months Improves Paediatric Slow Transit Constipation (STC). Neuromodulation. 2018. doi:10.1111/ner.12734
  23. Hunter C, Davé N, Diwan S, Deer T. Neuromodulation of pelvic visceral pain: Review of the literature and case series of potential novel targets for treatment. Pain Pract. 2013. doi:10.1111/j.1533-2500.2012.00558.x
  24. Pangarkar S, Miedema ML. Pulsed Versus Conventional Radio Frequency Ablation for Lumbar Facet Joint Dysfunction. Curr Phys Med Rehabil Reports. 2014. doi:10.1007/s40141-013-0040-z
  25. Van Boxem K. Continuous and pulsed radiofrequency: An update. Reg Anesth Pain Med. 2016.
  26. Hetta DF, Mohamed AA, Abdel Eman RM, Abd El Aal FA, Helal ME. Pulsed Radiofrequency of the Sacral Roots Improves the Success Rate of Superior Hypogastric Plexus Neurolysis in Controlling Pelvic and Perineal Cancer Pain. Pain Physician. 2020;23(2):149-157.
  27. Schu S, Gulve A, Eldabe S, et al. Spinal Cord Stimulation of the Dorsal Root Ganglion for Groin Pain-A Retrospective Review. Pain Pract. 2015. doi:10.1111/papr.12194
  28. Campos-Ríos A, Rueda-Ruzafa L, Herrera-Pérez S, Rivas-Ramírez P, Lamas JA. Tetrodotoxin: A New Strategy to Treat Visceral Pain?. Toxins (Basel). 2021;13(7):496. Published 2021 Jul 16. doi:10.3390/toxins13070496

Original Version of the Topic

Sayed E. Wahezi, MD, Sunil Thomas, MD. Differential diagnosis and treatment of visceral pain in the pelvis and abdomen. 9/8/2015.

Previous Revision(s) of the Topic

Ameet S Nagpal, MD, MS, MEd, Darrell Vydra, DO, DPT, Caleb Seale, MD. Differential diagnosis and treatment of visceral pain in the pelvis and abdomen. 11/19/2019.

Author Disclosure

Ameet S Nagpal, MD, MS, MEd, MBA
Nothing to Disclose

Aaron Yearsley, DO
Nothing to Disclose